0775:HKG
CK Life Sciences Intl (Holdings) Inc
၀.၅၁ HK$
၀.၀၀%
(၀.၀၀) 1D
အောက် ၁၆, GMT+၈ ၁၆:၀၈:၁၄ · HKD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 0775...
Open
၀.၅၁ HK$
High
၀.၅၂ HK$
Low
၀.၅၁ HK$
Mkt. cap
၄၉၀.၁၆ ဋေ
Avg. vol.
၁.၆၆ သန်း
Volume
၉.၅၆ သိန်း
52-wk high
၁.၀၂ HK$
52-wk low
၀.၅၁ HK$
EPS
-၀.၀၁ HK$
Shares outstanding
၉၆၁.၁၁ ဋေ
No. of employees
၂ ထောင်
Open
၀.၅၁ HK$
High
၀.၅၂ HK$
Low
၀.၅၁ HK$
Mkt. cap
၄၉၀.၁၆ ဋေ
Avg. vol.
၁.၆၆ သန်း
Volume
၉.၅၆ သိန်း
52-wk high
၁.၀၂ HK$
52-wk low
၀.၅၁ HK$
EPS
-၀.၀၁ HK$
Shares outstanding
၉၆၁.၁၁ ဋေ
No. of employees
၂ ထောင်
News stories
From web sources and news partners
mykxlg.com
·
ပြီးခဲ့သည့် ၅၆ မိနစ်
OpenWorld (NASDAQ: OPNW) Signs Definitive Merger Agreement to Acquire Blocksight
Yahoo Finance
·
ပြီးခဲ့သည့် ၂၇ မိနစ်
Black Monday Fears Fade as Nasdaq Futures Rally After Friday Selloff
Pulse 2.0
·
ပြီးခဲ့သည့် ၃၈ မိနစ်
Nasdaq Completes Acquisition Of LeveL Markets To Advance Always-On Trading Strategy
Bloomberg.com
·
ပြီးခဲ့သည့် ၃ နာရီ
US Stock Futures Rise Ahead of Busy Earnings Week: Markets Wrap
Profile
CK Life Sciences International Inc., or CK Life Sciences, is a subsidiary of CK Hutchison Holdings. It is engaged in research and development, commercialization, marketing and sale of biotechnology products. The chairman is Victor Li Tzar-kuoi, the eldest son of Li Ka-shing, the chairman of Cheung Kong Holdings.
It was established in 2000 and listed on the Hong Kong Stock Exchange via Growth Enterprise Market in 2002. It was transferred to Main Board of the Hong Kong Stock Exchange in 2008.
CK Life Sciences has operations in Australia, and in 2012 acquired an Australian salt company as part of its expansion into the agricultural sector.
The company divested its Canadian subsidiary WEX Pharmaceuticals to Virios Therapeutics for $100 million in October 2024. Wikipedia
About CK Life Sciences Intl (Holdings) Inc